Personalized Diagnostics Ventana is a Roche subsidiary focused on automated tissue processing and slide staining for cancer diagnostics, offering integrated platforms that support anatomic pathology and companion diagnostics. Sales opportunities lie in expanding automated staining workflows, reagent supply, and turnkey histology solutions to hospitals, CROs, and pharma partners pursuing personalized medicine.

Drug Development Ventana collaborates with Roche to accelerate drug discovery and companion diagnostics development. Target opportunities include partnering with biotech and pharma companies on immunohistochemistry assays, MTAP protein level confirmation, and co-developed diagnostic tests to accompany targeted therapies.

R&D Expansion Ventana is investing in next-generation CPU IP and chiplet designs for data centers, automotive, 5G, and AI applications, signaling a growth engine in high-performance computing. Potential cross-sell exists for specialized lab IT infrastructure, workflow management software, and automation integration tied to research labs and clinical facilities.

Quality & Compliance Historical FDA-related recalls and regulatory actions highlight the need for robust quality assurance in diagnostics kits. This indicates a market demand for validated, reliable reagents and maintenance services, offering opportunities to present comprehensive QA/QC services, supply chain resilience, and training for lab teams.

Global Lab Network Ventana serves clinical histology and drug development labs worldwide with instrument and reagent solutions. Growth opportunities include expanding across hospital networks, CROs, and academic medical centers, plus regional support bundles, maintenance contracts, and user training programs to reduce errors and increase assay throughput.